Difference between revisions of "Priontex"
Jump to navigation
Jump to search
m (using singular name for category) |
m (fixed missing image issue) |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 17: | Line 17: | ||
|date= | |date= | ||
|title=Products and Services | |title=Products and Services | ||
| − | |url= | + | |url=https://www.priontex.com/products/ |
| − | |accessdate= | + | |accessdate=2022-11-05 |
}}</ref> | }}</ref> | ||
== Circumcision Procedure Kit == | == Circumcision Procedure Kit == | ||
| − | [[Image:Priontex Circumcision Pack - Sealed.png | + | [[Image:Priontex Circumcision Pack - Sealed.png|thumb|A sealed "circumcision procedure kit" with Priontex logo]] |
| − | [[Image:Priontex Circumcision Pack - Opened.png | + | [[Image:Priontex Circumcision Pack - Opened.png|thumb|An opened "circumcision procedure kit" manufactured by Priontex.]] |
On their website, the "circumcision procedure kit" is be the only such "procedure pack" that they offer, (Last referenced: 5/13/2012),<ref>{{REFweb | On their website, the "circumcision procedure kit" is be the only such "procedure pack" that they offer, (Last referenced: 5/13/2012),<ref>{{REFweb | ||
| Line 42: | Line 42: | ||
|url=http://www.priontex.com/products-n-services-custom-procedure-packs.html | |url=http://www.priontex.com/products-n-services-custom-procedure-packs.html | ||
|accessdate=2012-05-12 | |accessdate=2012-05-12 | ||
| − | }}</ref> which means that they are capitalizing greatly on the endorsement of circumcision as an [[HIV]] preventative measure as endorsed by the [[WHO]]. Priontex is in direct competition with [[PrePex]], another manufacturer of circumcision devices. | + | }}</ref> which means that they are capitalizing greatly on the endorsement of [[circumcision]] as an [[HIV]] preventative measure as endorsed by the [[WHO]]. Priontex is in direct competition with [[PrePex]], another manufacturer of circumcision devices. |
== Quote from the Priontex Website == | == Quote from the Priontex Website == | ||
| Line 50: | Line 50: | ||
|Author= | |Author= | ||
|Source=Priontex Website | |Source=Priontex Website | ||
| − | |ref=<ref>[ | + | |ref=<ref>[https://www.priontex.com/products/custom-procedure-packs-and-trays/ Priontex Website] (5/13/2012)</ref> |
}} | }} | ||
| + | ==Circumcision does not prevent HIV infection== | ||
| + | === Population-based studies === | ||
| + | {{Population-based studies}} | ||
| + | ===Two African surveys=== | ||
| + | The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa. | ||
| + | |||
| + | French scientist [[Michel Garenne]], Ph.D. has published two reports in 2022 comparing the incidence of HIV infection in [[circumcised]] and [[intact]] men. | ||
| + | |||
| + | In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported: | ||
| + | <blockquote> | ||
| + | In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.<ref name="garenne2022A">{{REFjournal | ||
| + | |last=Garenne | ||
| + | |first=Michel | ||
| + | |init=M | ||
| + | |author-link=Michel Garenne | ||
| + | |title=Changing relationships between HIV prevalence and circumcision in Lesotho | ||
| + | |url=https://pubmed.ncbi.nlm.nih.gov/35373731/ | ||
| + | |date=2022-04-04 | ||
| + | |journal=J Biosoc Sci | ||
| + | |volume=online ahead of print | ||
| + | |pages=1-16 | ||
| + | |DOI=10.1017/S0021932022000153 | ||
| + | |pubmedID=35373731 | ||
| + | |accessdate=2022-11-05 | ||
| + | }}</ref> | ||
| + | </blockquote> | ||
| + | In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported: | ||
| + | <blockquote> | ||
| + | "Results matched earlier observations made in South Africa that [[circumcised]] and [[intact]] men had similar levels of HIV infection."<ref name="garenne2022B">{{REFjournal | ||
| + | |last=Garenne | ||
| + | |first=Michael | ||
| + | |init=M | ||
| + | |author-link= | ||
| + | |etal=no | ||
| + | |title=Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa | ||
| + | |trans-title= | ||
| + | |language= | ||
| + | |journal=J Biosoc Sci | ||
| + | |location= | ||
| + | |date=2022-10-26 | ||
| + | |season= | ||
| + | |volume= | ||
| + | |issue= | ||
| + | |article= | ||
| + | |page= | ||
| + | |pages=1-13 | ||
| + | |url=https://www.cambridge.org/core/journals/journal-of-biosocial-science/article/abs/ageincidence-and-prevalence-of-hiv-among-intact-and-circumcised-men-an-analysis-of-phia-surveys-in-southern-africa/CAA7E7BD5A9844F41C6B7CC3573B9E50 | ||
| + | |archived= | ||
| + | |quote= | ||
| + | |pubmedID=36286328 | ||
| + | |pubmedCID= | ||
| + | |DOI=10.1017/S0021932022000414 | ||
| + | |accessdate=2022-11-05 | ||
| + | }}</ref></blockquote> | ||
{{LINKS}} | {{LINKS}} | ||
| − | *[ | + | *[https://www.priontex.com/ Priontex website] |
{{REF}} | {{REF}} | ||
Latest revision as of 18:07, 9 November 2022
Priontex is a company based in South Africa.[1] The company manufactures re-usable medical laminate, theater textiles, clean room suits and procedure packs.[2]
Contents
Circumcision Procedure Kit
On their website, the "circumcision procedure kit" is be the only such "procedure pack" that they offer, (Last referenced: 5/13/2012),[3] and USAID has approved them as a global supplier for these "male circumcision kits",[4] which means that they are capitalizing greatly on the endorsement of circumcision as an HIV preventative measure as endorsed by the WHO. Priontex is in direct competition with PrePex, another manufacturer of circumcision devices.
Quote from the Priontex Website
| “ | From the Priontex Website Male circumcision is believed to reduce the risk of contracting HIV. International humanitarian aid organisations are facilitating the practice of voluntary adult in male clinical circumcision procedures in Southern Africa. Priontex developed a disposable circumcision kit in conjunction with these organisations and is one of the leading manufacturer and supplier of adult male circumcision kits in Sub-Saharan Africa. USAID has confirmed that Priontex is an approved global supplier for the production of male circumcision kits. (Priontex Website)[5] |
Circumcision does not prevent HIV infection
Population-based studies
September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:
- Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[6]
- Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[7]
No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.
Two African surveys
The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa.
French scientist Michel Garenne, Ph.D. has published two reports in 2022 comparing the incidence of HIV infection in circumcised and intact men.
In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported:
In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.[8]
In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported:
"Results matched earlier observations made in South Africa that circumcised and intact men had similar levels of HIV infection."[9]
External links
References
- ↑
Products and Services
, Priontex Products and Services. Retrieved 12 May 2012.
Quote:Priontex is South Africa’s leading manufacturer...
- ↑
Products and Services
, Priontex Products and Services. Retrieved 5 November 2022.
Quote:Priontex is South Africa’s leading manufacturer of superior quality re-usable medical laminate, theatre textiles, clean room suits and procedure packs
- ↑
Products and Services: Custom Procedure Packs
, Priontex Products and Services. Retrieved 12 May 2012. - ↑
Products and Services: Custom Procedure Packs
, Priontex Products and Services. Retrieved 12 May 2012.
Quote:USAID has confirmed that Priontex is an approved global supplier for the production of male circumcision kits.
- ↑ Priontex Website (5/13/2012)
- ↑
Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
Quote:We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
- ↑ Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
- ↑ Garenne M. Changing relationships between HIV prevalence and circumcision in Lesotho. J Biosoc Sci. 4 April 2022; online ahead of print: 1-16. PMID. DOI. Retrieved 5 November 2022.
- ↑ Garenne M. Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa. J Biosoc Sci. 26 October 2022; : 1-13. PMID. DOI. Retrieved 5 November 2022.
